Nureca Technologies Private Limited, the manufacturing subsidiary of Nureca Limited, has successfully completed its annual ...

You need to enable JavaScript to run this app. RAPS.org needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use ...

"The successful FDA Type D meeting provides darovasertib ... patients with metastatic uveal melanoma (MUM), where a Phase 2/3 registration-enabling trial of the darovasertib and crizotinib ...

Nureca Technologies Private Limited , the manufacturing subsidiary of Nureca Limited, has successfully completed its annual registration with the United States Food and Drug Administration (US FDA).

has successfully completed its annual registration with the United States Food and Drug Administration (US FDA). The company's manufacturing facility in Mohali, Punjab is now officially listed ...